Novacyt S.A. (CDI) (NCYT)

Sector:

Health Care

Index:

FTSE AIM All-Share

39.50p
   
  • Change Today:
      1.25p
  • 52 Week High: 118.00p
  • 52 Week Low: 37.20p
  • Currency: UK Pounds
  • Shares Issued: 70.63m
  • Volume: 197,631
  • Market Cap: £27.90m
  • RiskGrade: 453
  • Beta: 0.00

NCYT Overview

The Novacyt Group is a rapidly growing, international diagnostics group with a growing portfolio of cancer and infectious disease products and services. Through its proprietary technology platform, NOVAPrep®, and molecular platform, genesig®, Novacyt is able to provide an extensive range of oncology and infectious disease diagnostic products across an extensive international distributor network. The Group has diversified sales from diagnostic reagents used in oncology, microbiology, haematology and serology markets, and its global customers and partners include major corporates.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -190.2% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 1.4 n/a
Pr/Book 0.6  
Latest F'cast
Revenue 84.8% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

NCYT Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 277.20 165.17 194.00p 4.4 n/a n/a n/a 0.0%
31-Dec-21 92.60 (5.66) (9.00)p n/a n/a n/a n/a 0.0%
31-Dec-22 21.04 (20.05) (31.00)p n/a n/a n/a n/a 0.0%
31-Dec-23 10.62 (24.46) (34.00)p n/a n/a n/a n/a 0.0%
31-Dec-24 19.63 (39.43) (55.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

NCYT Company Announcements

Liquidity Agreement Monthly Update and TVR 02-May-2025 12:30 RNS
Full Year 2024 Results 30-Apr-2025 07:00 RNS
Notice of Results 22-Apr-2025 07:00 RNS

Latest NCYT Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

NCYT Market Data

Currency UK Pounds
Share Price 39.50p
Change Today 1.25p
% Change 3.27 %
52 Week High 118.00p
52 Week Low 37.20p
Volume 197,631
Shares Issued 70.63m
Market Cap £27.90m
Beta 0.00
RiskGrade 453

NCYT Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
63.08% above the market average63.08% above the market average63.08% above the market average63.08% above the market average63.08% above the market average
76.47% above the sector average76.47% above the sector average76.47% above the sector average76.47% above the sector average76.47% above the sector average
Price Trend
54.68% below the market average54.68% below the market average54.68% below the market average54.68% below the market average54.68% below the market average
35.14% below the sector average35.14% below the sector average35.14% below the sector average35.14% below the sector average35.14% below the sector average
Income Not Available
Growth
7.44% above the market average7.44% above the market average7.44% above the market average7.44% above the market average7.44% above the market average
2.86% above the sector average2.86% above the sector average2.86% above the sector average2.86% above the sector average2.86% above the sector average

NCYT Dividends

No dividends found

Trades for 09-May-2025

Time Volume / Share Price
16:35 6 @ 39.50p
16:35 6 @ 39.50p
16:18 3,000 @ 38.80p
16:17 3,000 @ 38.80p
16:17 3,000 @ 38.80p

NCYT Key Personnel

CFO Steve Gibson

Top of Page